(19)
(11) EP 4 205 130 A1

(12)

(43) Date of publication:
05.07.2023 Bulletin 2023/27

(21) Application number: 21904209.0

(22) Date of filing: 07.12.2021
(51) International Patent Classification (IPC): 
G16H 10/20(2018.01)
G06Q 10/10(2023.01)
G16H 15/00(2018.01)
 G06F 40/10(2020.01)
G16H 10/60(2018.01)
G16H 50/70(2018.01)
(52) Cooperative Patent Classification (CPC):
G16H 15/00; G16H 10/60; G16H 10/20
(86) International application number:
PCT/US2021/062095
(87) International publication number:
WO 2022/125480 (16.06.2022 Gazette 2022/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.12.2020 US 202063122677 P
24.05.2021 WO PCT/US2021/033900

(71) Applicant: Akyrian Systems LLC
New York, NY 10012 (US)

(72) Inventors:
  • IKEGUCHI, Edward
    New York, NY 10012 (US)
  • JACKSON, Peter, T.
    Brooklyn, NY 11231 (US)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) IMPROVED CLINICIAN-CENTERED CLINICAL TRIAL VERIFICATION SYSTEM AND METHOD